1 |
MASP2
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Narsoplimab
Narsoplimab
💬
|
Narsoplimab
| 4件: 64 64, 66, 109, 222 💬 |
2 |
CFD
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Danicopan
Danicopan
💬
|
Danicopan
| 1件: 62 62 💬 |
3 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Thrombomodulin alfa
Thrombomodulin alfa
💬
|
Thrombomodulin Alfa
| 1件: 85 85 💬 |
4 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Dabigatran etexilate
Dabigatran etexilate
💬
|
Dabigatran etexilate
| 2件: 51 51, 75 💬 |
5 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Dabigatran
Dabigatran
💬
|
Dabigatran
| 5件: 51 51, 75, 85, 91, 124 💬 |
6 |
F8
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Desmopressin
Desmopressin
💬
|
Desmopressin
| 6件: 6 6, 64, 72, 75, 225, 288 💬 |
7 |
F9
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬
|
Emicizumab
| 1件: 288 288 💬 |
8 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Apixaban
Apixaban
💬
|
Apixaban
| 1件: 222 222 💬 |
9 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Rivaroxaban
Rivaroxaban
💬
|
Rivaroxaban
| 4件: 46 46, 49, 91, 210 💬 |
10 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Edoxaban
Edoxaban
💬
|
Edoxaban
| 2件: 46 46, 88 💬 |
11 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬
|
Emicizumab
| 1件: 288 288 💬 |
12 |
SERPIND1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Sulodexide
Sulodexide
💬
|
Sulodexide
| 2件: 51 51, 271 💬 |
13 |
KLKB1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Conestat alfa
Conestat alfa
💬
|
Conestat alfa
| 1件: 61 61 💬 |
14 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Adomiparin
Adomiparin
💬
|
Heparin
| 11件: 47 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317 💬 |
15 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Adomiparin
Adomiparin
💬
|
Enoxaparin
| 1件: 46 46 💬 |
16 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Adomiparin
Adomiparin
💬
|
Parnaparin
| 1件: 97 97 💬 |
17 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Sulodexide
Sulodexide
💬
|
Sulodexide
| 2件: 51 51, 271 💬 |
18 |
PLG
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A | Aminocaproic acid
Aminocaproic acid
💬
|
Aminocaproic acid
| 1件: 70 70 💬 |
19 |
PLG
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A | Tranexamic acid
Tranexamic acid
💬
|
Tranexamic acid
| 7件: 46 46, 70, 215, 227, 274, 288, 299 💬 |
20 |
CFB
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Iptacopan
Iptacopan
💬
|
Iptacopan
| 5件: 61 61, 62, 66, 109, 222 💬 |
21 |
C1R
💬
| 6件: Phagosome Phagosome, Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Conestat alfa
Conestat alfa
💬
|
Conestat alfa
| 1件: 61 61 💬 |
22 |
C1S
💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Conestat alfa
Conestat alfa
💬
|
Conestat alfa
| 1件: 61 61 💬 |
23 |
C1S
💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Sutimlimab
Sutimlimab
💬
|
Sutimlimab
| 1件: 61 61 💬 |
24 |
C3
💬
| 17件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phagosome, Complement and coagulation cascades, Neutrophil extracellular trap formation, Alcoholic liver disease, Shigellosis, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, Staphylococcus aureus infection, Tuberculosis, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Viral carcinogenesis, Systemic lupus erythematosus | Pegcetacoplan
Pegcetacoplan
💬
|
Pegcetacoplan
| 4件: 2 2, 61, 62, 222 💬 |
25 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Eculizumab
Eculizumab
💬
|
Eculizumab
| 7件: 11 11, 13, 14, 61, 62, 109, 222 💬 |
26 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Ravulizumab
Ravulizumab
💬
|
Ravulizumab
| 7件: 2 2, 11, 13, 50, 62, 66, 109 💬 |
27 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Nomacopan
Nomacopan
💬
|
Nomacopan
| 3件: 62 62, 109, 162 💬 |
28 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Pozelimab
Pozelimab
💬
|
Pozelimab
| 2件: 11 11, 62 💬 |
29 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Crovalimab
Crovalimab
💬
|
Crovalimab
| 2件: 62 62, 109 💬 |
30 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Vilobelimab
Vilobelimab
💬
|
Vilobelimab
| 3件: 43 43, 44, 269 💬 |
31 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Zilucoplan
Zilucoplan
💬
|
Zilucoplan
| 3件: 2 2, 11, 62 💬 |
32 |
C5AR1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Alcoholic liver disease, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Avacopan
Avacopan
💬
|
Avacopan
| 3件: 43 43, 44, 222 💬 |
33 |
VWF
💬
| 8件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Complement and coagulation cascades, Platelet activation, Neutrophil extracellular trap formation, Human papillomavirus infection, Coronavirus disease - COVID-19 | Caplacizumab
Caplacizumab
💬
|
Caplacizumab
| 1件: 64 64 💬 |